KATRINA FERNANDES: Open Payments
NPI 1366026999 · MOORPARK, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,889 in 83 payments from 11 companies in 2025. Trend: 2023 $23 · 2024 $0 · 2025 $1,889
Food & beverage: $1,812Education: $77
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $599 |
| Janssen Biotech, Inc. | 15 | $336 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 18 | $335 |
| Ardelyx, Inc. | 12 | $259 |
| Madrigal Pharmaceuticals | 4 | $111 |
| QOL Medical, LLC | 3 | $79 |
| Novo Nordisk Inc | 2 | $57 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $31 |
| GENZYME CORPORATION | 1 | $29 |
| Echosens North America, Inc. | 1 | $28 |
Products named: RINVOQ, TREMFYA, XIFAXAN, IBSRELA, REZDIFFRA, SKYRIZI, Sucraid, LINZESS.
Industry payments across CA — which companies pay providers there.
